Silverman Joshua

CIK 000152485814 companiesLAS VEGAS, NV

SEC Profile

Transactions

Companies

Filings

CIK

0001524858

Recent Transactions

50 trades

Purchase
PharmaCyte Biotech, Inc.$PMCB
Common Stock
2026-01-07$0.83/sh+40,000→ 416,250 total
Purchase
PharmaCyte Biotech, Inc.$PMCB
Common Stock
2026-01-06$0.79/sh+30,000→ 376,250 total
Purchase
PharmaCyte Biotech, Inc.$PMCB
Common Stock
2026-01-05$0.78/sh+30,000→ 346,250 total
Award
Petros Pharmaceuticals, Inc.$PTPI
Common Stock
2026-01-02+4,375,000→ 4,415,450 total
Tax Payment
PharmaCyte Biotech, Inc.$PMCB
Common Stock
2025-12-12$1.02/sh−258,750→ 316,250 total
Award
PharmaCyte Biotech, Inc.$PMCB
Common Stock
2025-12-12+575,000→ 575,000 total
Award
Q/C TECHNOLOGIES, INC.$QCLS
Common stock
2025-11-14+91,356→ 100,029 total
Award
StableX Technologies, Inc.$SBLX
Employee Stock Option (Right to Buy
2025-10-31+220,513→ 220,513 total
Award
TAO Synergies Inc.$TAOX
Common Stock, par value $0.0001 per share
2025-10-17+100,000→ 126,681 total
Tax Payment
TAO Synergies Inc.$TAOX
Common Stock, par value $0.0001 per share
2025-10-17$7.23/sh−40,000→ 86,681 total
Award
Q/C TECHNOLOGIES, INC.$QCLS
Common stock
2025-10-03+8,644→ 8,673 total
Award
TAO Synergies Inc.$TAOX
Employee Stock Option (right to buy)
2025-08-06+36,000→ 36,000 total
Award
TAO Synergies Inc.$TAOX
Common Stock, par value $0.0001 per share
2025-06-30+41,919→ 43,449 total
Tax Payment
TAO Synergies Inc.$TAOX
Common Stock, par value $0.0001 per share
2025-06-30$7.85/sh−16,768→ 26,681 total
Award
FEMASYS INC$FEMY
Stock Option (Right to Buy)
2025-06-25+17,600→ 17,600 total
Award
Petros Pharmaceuticals, Inc.$PTPI
Common Stock
2025-02-19+1,000,000→ 1,011,237 total
Exercise/Conversion
StableX Technologies, Inc.$SBLX
Cash-Settled Restricted Stock Units
2024-12-02+97,368→ 97,368 total
Award
StableX Technologies, Inc.$SBLX
Common Stock
2024-12-02+146,052→ 189,323 total
Disposition to Issuer
StableX Technologies, Inc.$SBLX
Common Stock
2024-12-02−6,166→ 43,271 total
Award
FEMASYS INC$FEMY
Stock Option (Right to Buy)
2024-07-12+17,600→ 17,600 total
Award
TAO Synergies Inc.$TAOX
Stock Option (Right to Buy)
2024-04-08+800→ 800 total
Award
Petros Pharmaceuticals, Inc.$PTPI
Stock Option (Right to Buy)
2023-12-21+40,000→ 40,000 total
Award
FEMASYS INC$FEMY
Stock Option (Right to Buy)
2023-11-21+17,000→ 17,000 total
Award
PharmaCyte Biotech, Inc.$PMCB
Stock Option (Right to Buy)
2023-11-20+170,000→ 170,000 total
Sale
StableX Technologies, Inc.$SBLX
Common Stock
2023-08-01$0.82/sh−12,740→ 395,493 total
Award
Q/C TECHNOLOGIES, INC.$QCLS
Employee Stock Option (Right to Buy)
2023-06-07+200,000→ 200,000 total
Sale
StableX Technologies, Inc.$SBLX
Common Stock
2023-05-03$0.49/sh−11,927→ 408,233 total
Exercise/Conversion
Petros Pharmaceuticals, Inc.$PTPI
Restricted Stock Units
2023-04-26−6,722→ 0 total
Exercise/Conversion
Petros Pharmaceuticals, Inc.$PTPI
Common Stock
2023-04-26+6,722→ 11,237 total
Award
Petros Pharmaceuticals, Inc.$PTPI
Stock Option (Right to Buy)
2023-04-10+39,000→ 39,000 total
Award
TAO Synergies Inc.$TAOX
Stock Option (Right to Buy)
2023-03-29+20,000→ 20,000 total
Award
StableX Technologies, Inc.$SBLX
Common Stock
2023-02-01+197,333→ 420,160 total
Sale
StableX Technologies, Inc.$SBLX
Common Stock
2023-01-30$0.71/sh−7,171→ 222,827 total
Exercise/Conversion
Petros Pharmaceuticals, Inc.$PTPI
Common Stock
2023-01-20+2,515→ 4,515 total
Exercise/Conversion
Petros Pharmaceuticals, Inc.$PTPI
Restricted Stock Units
2023-01-20−2,515→ 0 total
Sale
TAO Synergies Inc.$TAOX
Common Stock, par value $0.0001 per share
2022-12-16$1.17/sh−19,012→ 38,238 total
Award
TAO Synergies Inc.$TAOX
Stock Option (Right to Buy)
2022-11-15+144,000→ 144,000 total
Award
TAO Synergies Inc.$TAOX
Stock Option (Right to Buy)
2022-11-15+75,000→ 75,000 total
Sale
StableX Technologies, Inc.$SBLX
Common Stock
2022-11-01$0.59/sh−7,171→ 229,998 total
Sale
StableX Technologies, Inc.$SBLX
Common Stock
2022-05-11$0.82/sh−12,855→ 237,169 total
Award
Petros Pharmaceuticals, Inc.$PTPI
Restricted Stock Units
2022-04-07+67,227→ 67,227 total
Award
TAO Synergies Inc.$TAOX
Stock Option (Right to Buy)
2022-04-05+1,500→ 1,500 total
Other
TAO Synergies Inc.$TAOX
Stock Option (Right to Buy)
2022-04-05+0→ 0 total
Award
StableX Technologies, Inc.$SBLX
Common Stock
2022-02-01+114,729→ 250,024 total
Award
Petros Pharmaceuticals, Inc.$PTPI
Restricted Stock Units
2021-12-22+25,156→ 25,156 total
Purchase
Q/C TECHNOLOGIES, INC.$QCLS
Common Stock
2021-11-26$7.55/sh+5,000→ 88,775 total
Purchase
Q/C TECHNOLOGIES, INC.$QCLS
Common Stock
2021-11-24$6.30/sh+6,734→ 80,509 total
Purchase
Q/C TECHNOLOGIES, INC.$QCLS
Common Stock
2021-11-24$7.09/sh+3,266→ 83,775 total
Award
Q/C TECHNOLOGIES, INC.$QCLS
Restricted Stock Units
2021-10-14+600,000→ 600,000 total
Award
TAO Synergies Inc.$TAOX
Common Stock, par value $0.0001 per share
2021-07-13+90,000→ 105,000 total

Companies

Recent Filings

Address

C/O PHARMACYTE BIOTECH, INC. 3960 HOWARD HUGHES PARKWAY, SUITE 500

LAS VEGAS, NV, 89169

View on SEC.gov